Niagen Bioscience Inc (NAGE)
Niagen Bioscience stock today
Niagen Bioscience closed at $2.33 on October 30, 2026, down 6.80% on the day. Over the past year it returned -67.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $186 million.
| Period | NAGE | S&P 500 (SPY) |
|---|---|---|
| 1 month | -20.2% | -0.9% |
| 3 months | -29.8% | +2.1% |
| Year to date | -63.4% | +11.7% |
| 1 year | -67.2% | +12.4% |
| 3 years | +76.5% | +88.5% |
| 5 years | -62.4% | +76.0% |
Key statistics
- Market value
- $186M
- P/E (trailing)
- 12.9
- Price / sales
- 1.4
- 52-week range
- $2.33 to $7.54
- Next report
- Nov 4, 2026
About Niagen Bioscience
Niagen Bioscience Inc develops and sells nutritional supplements and health products.
Sector: Consumer Staples
More on Niagen Bioscience
- Financials: revenue, earnings and segmentsRevenue +30% in the year to Dec 2025
- Valuation: P/E history and peersP/E 12.9
- Returns: what $1,000 became$1,000 ten years ago is $814.69 today
No forecast, no recommendation. This page describes Niagen Bioscience Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.